Premium
A blastic plasmacytoid dendritic cell neoplasm‐like phenotype identifies a subgroup of npm1‐mutated acute myeloid leukemia patients with worse prognosis
Author(s) -
Minetto Paola,
Guolo Fabio,
Clavio Marino,
Kunkl Annalisa,
Colombo Nicoletta,
Carminati Enrico,
Giani Livia,
Ballerini Filippo,
Lemoli Roberto Massimo,
Gobbi Marco,
Miglino Maurizio
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24956
Subject(s) - npm1 , idarubicin , immunophenotyping , cytarabine , myeloid leukemia , myeloid , fludarabine , medicine , minimal residual disease , oncology , leukemia , bone marrow , cd33 , cancer research , cebpa , chemotherapy , hematology , immunology , cd34 , biology , mutation , stem cell , antigen , gene , karyotype , cyclophosphamide , genetics , chromosome